GHP Investment Advisors Inc. lowered its holdings in Encompass Health Co. (NYSE:EHC – Free Report) by 3.6% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,792 shares of the company’s stock after selling 695 shares during the period. GHP Investment Advisors Inc.’s holdings in Encompass Health were worth $1,735,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in the business. State Street Corp grew its stake in shares of Encompass Health by 0.7% in the third quarter. State Street Corp now owns 3,025,769 shares of the company’s stock worth $292,410,000 after acquiring an additional 21,329 shares in the last quarter. Geode Capital Management LLC grew its stake in Encompass Health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock worth $161,781,000 after purchasing an additional 20,547 shares in the last quarter. Copeland Capital Management LLC increased its holdings in Encompass Health by 0.7% during the 4th quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company’s stock worth $119,418,000 after purchasing an additional 8,548 shares during the period. Point72 Asset Management L.P. raised its position in Encompass Health by 2,458.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after purchasing an additional 835,135 shares in the last quarter. Finally, Thrivent Financial for Lutherans boosted its stake in shares of Encompass Health by 26.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock valued at $73,494,000 after buying an additional 156,938 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.
Encompass Health Trading Up 1.3 %
NYSE EHC opened at $99.86 on Friday. Encompass Health Co. has a one year low of $72.37 and a one year high of $104.55. The firm has a market cap of $10.06 billion, a PE ratio of 24.12, a P/E/G ratio of 1.18 and a beta of 0.90. The firm’s fifty day moving average is $96.28 and its two-hundred day moving average is $95.19. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on the stock. StockNews.com cut shares of Encompass Health from a “buy” rating to a “hold” rating in a report on Friday. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Friday. Truist Financial reissued a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. KeyCorp lifted their price target on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, Royal Bank of Canada increased their price objective on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. One investment analyst has rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Encompass Health presently has an average rating of “Buy” and an average target price of $107.33.
Get Our Latest Stock Report on Encompass Health
Encompass Health Company Profile
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Featured Stories
- Five stocks we like better than Encompass Health
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- About the Markup Calculator
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Insider Trades May Not Tell You What You Think
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.